Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Edding Genor Group HoldingsHKSE:06998 +0.33%15 Current Ratio is 1.00 as of Dec. 2025, which is 27% above its 10-year median of 0.79. GuruFocus rates HKSE:06998 with a GF Score™ of 15/100. The stock has 1 warning sign investors should review. Among 996 Drug Manufacturers companies, Edding Genor Group Holdings ranks worse than 82.93% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Edding Genor Group Holdings's current ratio for the quarter that ended in Dec. 2025 was 1.00.
Edding Genor Group Holdings has a current ratio of 1.00. It generally indicates good short-term financial strength.
The historical rank and industry rank for Edding Genor Group Holdings's Current Ratio or its related term are showing as below:
HKSE:06998'
s Current Ratio Range Over the Past 10 Years
Min: 0.58 Med: 0.79 Max: 1
Current: 1
During the past 2 years, Edding Genor Group Holdings's highest Current Ratio was 1.00. The lowest was 0.58. And the median was 0.79.
HKSE:06998's Current Ratio is ranked worse than 82.93% of 996
companies
in the Drug Manufacturers industry
Industry Median: 1.945
vs HKSE:06998: 1.00
Edding Genor Group Holdings (HKSE:06998) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Edding Genor Group Holdings Current Ratio Related Terms
Edding Genor Group Holdings Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Edding Genor Group Holdings Current Ratio Chart
Edding Genor Group Holdings Annual Data
Trend
Dec24
Dec25
Current Ratio
0.58
1.00
Edding Genor Group Holdings Semi-Annual Data
Dec24
Dec25
Current Ratio
0.58
1.00
HKSE:06998 vs ZTS: Current Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Edding Genor Group Holdings's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Edding Genor Group Holdings Current Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Edding Genor Group Holdings's Current Ratio distribution charts can be found below:
* The bar in red indicates where Edding Genor Group Holdings's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Edding Genor Group Holdings (HKSE:06998) has a Current Ratio of 1.00 as of Dec. 2025. This is 27% above median its historical median of 0.79. Over the past decade, Edding Genor Group Holdings' Current Ratio has ranged from 0.58 to 1.00. According to the industry distribution chart, Edding Genor Group Holdings ranks #826 out of 996 companies in the Drug Manufacturers industry, placing it in the top 82.9%.
Is Edding Genor Group Holdings' Current Ratio too high?
Edding Genor Group Holdings' current Current Ratio of 1.00 is 27% above median its 10-year median of 0.79. Over the past 10 years, this metric has ranged from a low of 0.58 to a high of 1.00. The Drug Manufacturers industry median Current Ratio is 1.95. Edding Genor Group Holdings' value of 1.00 is 48.6% below this industry median. Based on the distribution chart, Edding Genor Group Holdings ranks #826 out of 996 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Edding Genor Group Holdings has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Edding Genor Group Holdings' Current Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Edding Genor Group Holdings ranks #826 out of 996 companies for Current Ratio. This places Edding Genor Group Holdings in the lower half of its industry. The industry median Current Ratio is 1.95. Edding Genor Group Holdings' value of 1.00 is 48.6% below this benchmark. Historically, Edding Genor Group Holdings' own Current Ratio has ranged from 0.58 to 1.00 over the past decade. While the company's 10-year median is 0.79 vs. the industry median of 1.95, Edding Genor Group Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Drug Manufacturers company?
The median Current Ratio among Drug Manufacturers companies is 1.95, based on 996 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Edding Genor Group Holdings's current Current Ratio of 1.00 is 48.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median Current Ratio is 1.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Edding Genor Group Holdings's current Current Ratio is 1.00, which is 27% above median its own 10-year median of 0.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Edding Genor Group Holdings stock overvalued right now?
Edding Genor Group Holdings (HKSE:06998) has a current Current Ratio of 1.00. The current Current Ratio is 1.00, which is 27% above median its 10-year median of 0.79 and 48.6% below the Drug Manufacturers industry median of 1.95. Edding Genor Group Holdings' overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Edding Genor Group Holdings (HKSE:06998), the current Current Ratio is 1.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Edding Genor Group Holdings Ltd is an integrated specialty biopharmaceutical company, focusing on oncology, autoimmune diseases, cardiovascular diseases, respiratory diseases, and anti-infectives. Through the acquisition of branded drug assets from multinational pharmaceutical companies (MNCs) and licensing in development and commercialisation rights of patented drugs from international biopharmaceutical companies, it has established a portfolio of originator-branded and other drugs. The company has two reportable operating segments: Manufacturing and Distribution, which generates the maximum revenue, and Research and development. Geographically, it derives maximum revenue from the Chinese mainland, and the rest from the USA and other markets.
15GF Score
Get the complete analysis for HKSE:06998
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:06998 has been successfully added to your 
